The Relationship between ABO Blood Type and Outcomes in Severe and Critical COVID-19 Patients in the Covid ICU of the Hospital. Dr. M. Djamil Padang
DOI:
https://doi.org/10.59141/jiss.v5i08.1217Keywords:
COVID-19, Blood Type, Patient OutcomesAbstract
The spread of the Coronavirus Disease represents the most significant global health threat in recent decades. Blood type is among the risk factors associated with COVID-19, with certain blood types linked to increased severity and higher mortality rates. This research aims to assess the relationship between ABO blood type and outcomes in severe and critical COVID-19 patients in the ICU at RSUP Dr. M. Djamil Padang. The study is an observational analytical research utilizing a cross-sectional approach. Data were gathered from the medical records of COVID-19 patients from January to September through a total sampling method, resulting in 124 individuals meeting the inclusion criteria. The data were analyzed utilizing the Chi-Square test. The discoveries uncovered that male patients (54%) dwarfed female patients (46%). The larger part of patients were within the age range of 56-65 for years (33.9%). Patients with blood sort O were more predominant among those with extreme COVID-19 (31.3%) and basic COVID-19 (38.0%). The foremost common result was passing, happening in 56.0% of serious cases and 53.7% of basic cases. There was no factually noteworthy relationship between ABO blood sort and results in serious and basic COVID-19 patients, with a p-value of 0.778 (>0.05). The study concludes that there's no measurably critical affiliation between ABO blood sort and outcomes in extreme and basic COVID-19 patients within the ICU at Dr. M. Djamil Padang hospital.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Adissa Banenda, Dedy Kurnia, Gardenia Akhyar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.